Low effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2014/15 mid-season results

被引:1
|
作者
Pebody, R. G. [1 ]
Warburton, F. [1 ]
Ellis, J. [2 ]
Andrews, N. [1 ]
Thompson, C. [2 ]
von Wissmann, B. [3 ]
Green, H. K. [1 ]
Cottrell, S. [4 ]
Johnston, J. [5 ]
de Lusignan, S.
Moore, C. [6 ]
Gunson, R. [7 ]
Robertson, C. [9 ]
McMenamin, J. [3 ,8 ]
Zambon, M. [2 ]
机构
[1] Publ Hlth England Ctr Infect Dis Surveillance & C, London, England
[2] Microbiol Serv, Publ Hlth England Operat Directorate, London, England
[3] Hlth Protect Scotland, Glasgow, Lanark, Scotland
[4] Publ Hlth Wales, Cardiff, S Glam, Wales
[5] Publ Hlth Agcy Northern Ireland, Belfast, Antrim, North Ireland
[6] Publ Hlth Wales Mol Diagnost Unit, Cardiff, S Glam, Wales
[7] West Scotland Specialist Virol Ctr, Glasgow, Lanark, Scotland
[8] Univ Strathclyde, Glasgow, Lanark, Scotland
[9] Int Prevent Res Inst, Lyon, France
关键词
PCR;
D O I
暂无
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
In 2014/15 the United Kingdom experienced circulation of influenza A(H3N2) with impact in the elderly. Mid-season vaccine effectiveness (VE) shows an adjusted VE of 3.4% (95% CI: -44.8 to 35.5) against primary care consultation with laboratory-confirmed influenza and -2.3% (95% CI: -56.2 to 33.0) for A(H3N2). The low VE reflects mismatch between circulating viruses and the 2014/15 northern hemisphere A(H3N2) vaccine strain. Early use of antivirals for prophylaxis and treatment of vulnerable populations remains important.
引用
收藏
页码:6 / 12
页数:7
相关论文
共 50 条
  • [41] Interim estimates of the effectiveness of seasonal trivalent inactivated influenza vaccine in preventing influenza hospitalisations and primary care visits in Auckland, New Zealand, in 2014
    Turner, N.
    Pierse, N.
    Huang, Q. S.
    Radke, S.
    Bissielo, A.
    Thompson, M. G.
    Kelly, H.
    [J]. EUROSURVEILLANCE, 2014, 19 (42): : 19 - 24
  • [42] Influenza vaccine effectiveness against laboratory confirmed influenza in Greece during the 2013-2014 season: A test-negative study
    Lytras, Theodore
    Kossyvakis, Athanasios
    Melidou, Angeliki
    Exindari, Maria
    Gioula, Georgia
    Pogka, Vasiliki
    Malisiovas, Nikolaos
    Mentis, Andreas
    [J]. VACCINE, 2015, 33 (02) : 367 - 373
  • [43] Interim estimates of 2013/14 influenza clinical severity and vaccine effectiveness in the prevention of laboratory-confirmed influenza-related hospitalisation, Canada, February 2014
    McNeil, S. A.
    Shinde, V.
    Andrew, M.
    Hatchette, T. F.
    Leblanc, J.
    Ambrose, A.
    Boivin, G.
    Bowie, W. R.
    Diaz-Mitoma, F.
    ElSherif, M.
    Green, K.
    Haguinet, F.
    Halperin, S.
    Ibarguchi, B.
    Katz, K.
    Langley, J. M.
    Lagace-Wiens, P.
    Light, B.
    Loeb, M.
    McElhaney, J.
    MacKinnon-Cameron, D.
    McCarthy, A. E.
    Poirier, M.
    Powis, J.
    Richardson, D.
    Semret, M.
    Smith, S.
    Smyth, D.
    Stiver, G.
    Trottier, S.
    Valiquette, L.
    Webster, D.
    Ye, L.
    McGeer, A.
    [J]. EUROSURVEILLANCE, 2014, 19 (09): : 16 - 21
  • [44] Live attenuated influenza vaccine effectiveness against hospitalisation due to laboratory-confirmed influenza in children two to six years of age in England in the 2015/16 season
    Pebody, R.
    Sile, B.
    Warburton, F.
    Sinnathamby, M.
    Tsang, C.
    Zhao, H.
    Ellis, J.
    Andrews, N.
    [J]. EUROSURVEILLANCE, 2017, 22 (04): : 18 - 22
  • [45] Influenza vaccine effectiveness against hospitalisation due to laboratory-confirmed influenza in children in England in the 2015-2016 influenza season - a test-negative case-control study
    Boddington, N. L.
    Warburton, F.
    Zhao, H.
    Andrews, N.
    Ellis, J.
    Donati, M.
    Pebody, R. G.
    [J]. EPIDEMIOLOGY AND INFECTION, 2019, 147
  • [46] Case-Control Study of the Effectiveness of the 2010-2011 Seasonal Influenza Vaccine for Prevention of Laboratory-Confirmed Influenza Virus Infection in the Korean Adult Population
    Choi, Won Suk
    Noh, Ji Yun
    Seo, Yu Bin
    Baek, Ji Hyeon
    Lee, Jacob
    Song, Joon Young
    Park, Dae Won
    Lee, Jin Soo
    Cheong, Hee Jin
    Kim, Woo Joo
    [J]. CLINICAL AND VACCINE IMMUNOLOGY, 2013, 20 (06) : 877 - 881
  • [47] Influenza vaccine effectiveness against hospitalization with laboratory-confirmed influenza in Greece: A pooled analysis across six seasons, 2013-2014 to 2018-2019
    Mouratidou, Elisavet
    Lambrou, Angeliki
    Andreopoulou, Anastasia
    Gioula, Georgia
    Exindari, Maria
    Kossyvakis, Athanasios
    Pogka, Vasiliki
    Mentis, Andreas
    Georgakopoulou, Theano
    Lytras, Theodore
    [J]. VACCINE, 2020, 38 (12) : 2715 - 2724
  • [48] Effectiveness of seasonal influenza vaccine in preventing influenza primary care visits and hospitalisation in Auckland, New Zealand in 2015: interim estimates
    Bissielo, A.
    Pierse, N.
    Huang, Q.
    Thompson, M.
    Kelly, H.
    Mishin, V.
    Turner, N.
    [J]. EUROSURVEILLANCE, 2016, 21 (01): : 11 - 15
  • [49] Effectiveness of seasonal trivalent inactivated influenza vaccine in preventing influenza hospitalisations and primary care visits in Auckland, New Zealand, in 2013
    Turner, N.
    Pierse, N.
    Bissielo, A.
    Huang, Q. S.
    Radke, S.
    Baker, M. G.
    Widdowson, M. A.
    Kelly, H.
    [J]. EUROSURVEILLANCE, 2014, 19 (34): : 29 - 38
  • [50] Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: Results from the 2005-2006 season of dual A and B vaccine mismatch in Canada
    Skowronski, D. M.
    Masaro, C.
    Kwindt, T. L.
    Mak, A.
    Petric, M.
    Li, Y.
    Sebastian, R.
    Chong, M.
    Tam, T.
    De Serres, G.
    [J]. VACCINE, 2007, 25 (15) : 2842 - 2851